Literature DB >> 27376746

Lung protective properties of the volatile anesthetics.

Brian O'Gara1, Daniel Talmor2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27376746      PMCID: PMC4992441          DOI: 10.1007/s00134-016-4429-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Effects of sevoflurane and propofol on pulmonary inflammatory responses during lung resection.

Authors:  Yusuke Sugasawa; Keisuke Yamaguchi; Seiichiro Kumakura; Taisuke Murakami; Kenji Suzuki; Isao Nagaoka; Eiichi Inada
Journal:  J Anesth       Date:  2011-10-07       Impact factor: 2.078

2.  Anesthetic-induced improvement of the inflammatory response to one-lung ventilation.

Authors:  Elisena De Conno; Marc P Steurer; Moritz Wittlinger; Marco P Zalunardo; Walter Weder; Didier Schneiter; Ralph C Schimmer; Richard Klaghofer; Thomas A Neff; Edith R Schmid; Donat R Spahn; Birgit Roth Z'graggen; Martin Urner; Beatrice Beck-Schimmer
Journal:  Anesthesiology       Date:  2009-06       Impact factor: 7.892

3.  Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients.

Authors:  Thomas Schilling; Alf Kozian; Mert Senturk; Christof Huth; Annegret Reinhold; Göran Hedenstierna; Thomas Hachenberg
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

4.  Isoflurane Ameliorates Acute Lung Injury by Preserving Epithelial Tight Junction Integrity.

Authors:  Joshua A Englert; Alvaro A Macias; Diana Amador-Munoz; Miguel Pinilla Vera; Colleen Isabelle; Jiazhen Guan; Brady Magaoay; Margarita Suarez Velandia; Anna Coronata; Awapuhi Lee; Laura E Fredenburgh; Deborah J Culley; Gregory Crosby; Rebecca M Baron
Journal:  Anesthesiology       Date:  2015-08       Impact factor: 7.892

5.  Sevoflurane suppresses tumour necrosis factor-α-induced inflammatory responses in small airway epithelial cells after anoxia/reoxygenation.

Authors:  K Watanabe; C Iwahara; H Nakayama; K Iwabuchi; T Matsukawa; K Yokoyama; K Yamaguchi; Y Kamiyama; E Inada
Journal:  Br J Anaesth       Date:  2013-01-07       Impact factor: 9.166

6.  Effects of sevoflurane and propofol on pulmonary shunt fraction during one-lung ventilation for thoracic surgery.

Authors:  D H Beck; U R Doepfmer; C Sinemus; A Bloch; M R Schenk; W J Kox
Journal:  Br J Anaesth       Date:  2001-01       Impact factor: 9.166

7.  Oxidative stress status during exposure to propofol, sevoflurane and desflurane.

Authors:  B Allaouchiche; R Debon; J Goudable; D Chassard; F Duflo
Journal:  Anesth Analg       Date:  2001-10       Impact factor: 5.108

8.  Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis.

Authors:  Martin Bellgardt; Hagen Bomberg; Jenny Herzog-Niescery; Burkhard Dasch; Heike Vogelsang; Thomas P Weber; Claudia Steinfort; Waldemar Uhl; Stefan Wagenpfeil; Thomas Volk; Andreas Meiser
Journal:  Eur J Anaesthesiol       Date:  2016-01       Impact factor: 4.330

Review 9.  Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoing Surgery: A Systematic Review and Meta-analysis.

Authors:  Christopher Uhlig; Thomas Bluth; Kristin Schwarz; Stefanie Deckert; Luise Heinrich; Stefan De Hert; Giovanni Landoni; Ary Serpa Neto; Marcus J Schultz; Paolo Pelosi; Jochen Schmitt; Marcelo Gama de Abreu
Journal:  Anesthesiology       Date:  2016-06       Impact factor: 7.892

10.  Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation.

Authors:  T Schilling; A Kozian; M Kretzschmar; C Huth; T Welte; F Bühling; G Hedenstierna; T Hachenberg
Journal:  Br J Anaesth       Date:  2007-07-09       Impact factor: 9.166

View more
  5 in total

1.  Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?

Authors:  Jeremy R Beitler; Daniel Talmor
Journal:  Intensive Care Med       Date:  2022-09-03       Impact factor: 41.787

2.  Design and Rationale of the Sevoflurane for Sedation in Acute Respiratory Distress Syndrome (SESAR) Randomized Controlled Trial.

Authors:  Raiko Blondonnet; Laure-Anne Simand; Perine Vidal; Lucile Borao; Nathalie Bourguignon; Dominique Morand; Lise Bernard; Laurence Roszyk; Jules Audard; Thomas Godet; Antoine Monsel; Marc Garnier; Christophe Quesnel; Jean-Etienne Bazin; Vincent Sapin; Julie A Bastarache; Lorraine B Ware; Christopher G Hughes; Pratik P Pandharipande; E Wesley Ely; Emmanuel Futier; Bruno Pereira; Jean-Michel Constantin; Matthieu Jabaudon
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

Review 3.  Perioperative lung protective ventilation.

Authors:  Brian O'Gara; Daniel Talmor
Journal:  BMJ       Date:  2018-09-10

Review 4.  Immunomodulatory effects of anesthetics in obese patients.

Authors:  Luciana Boavista Barros Heil; Pedro Leme Silva; Paolo Pelosi; Patricia Rieken Macedo Rocco
Journal:  World J Crit Care Med       Date:  2017-08-04

5.  Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage.

Authors:  Favin S Babu; Xiaomei Liang; Garrett A Enten; Anthony J DeSantis; Brian F Volkman; Xianlong Gao; Matthias Majetschak
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.